中新网广州3月15日电 (蔡敏婕 胡颖仪 孙冰倩)针对难治性高血压这一长期困扰临床治疗的难题，广州某医疗团队开发出一种新的治疗方案。该方案通过综合手段对患者进行个体化治疗，结果显示近五成的患者在术后12周内达到了减少用药量的标准。
难治性高血压是指患者在使用了至少五种不同类型的降压药物后，血压仍然无法得到有效控制。这类患者往往面临着健康风险和生活质量下降的双重困扰。
广州医疗团队的这项新方案，通过结合药物治疗、生活方式调整以及可能的介入治疗，为患者提供了一种多管齐下的治疗策略。该方案的核心在于对每位患者的具体情况，包括血压波动特征、并发症情况以及生活方式等因素进行全面评估，从而制定个性化的治疗计划。
在实施新方案的过程中，医疗团队密切跟踪患者的血压变化，并根据实际情况调整治疗方案。研究发现，近五成的患者在术后12周内成功减少了降压药物的使用，这对于提高患者的生活质量，减少长期用药的副作用具有重要意义。
这项研究成果不仅为难治性高血压患者带来了新的希望，也为高血压的临床治疗提供了新的思路。随着研究的深入，预计将有更多的患者能够从这种新方案中受益。
英文标题：Guangzhou medical team offers new solution for resistant hypertension, nearly 50% of patients achieve drug reduction within 12 weeks
英文关键词：Hypertension treatment, new approach, drug reduction success
英文新闻内容：
A medical team in Guangzhou has developed a new treatment regimen for patients with resistant hypertension, a condition where blood pressure remains uncontrolled despite the use of at least five different types of antihypertensive drugs. The innovative approach, which combines pharmacological therapy, lifestyle adjustments, and potentially interventional treatments, offers patients a multidisciplinary strategy tailored to their individual needs.
The core of the new regimen is a comprehensive assessment of each patient’s specific circumstances, including blood pressure patterns, the presence of comorbidities, and lifestyle factors. Based on these assessments, individualized treatment plans are created.
During the implementation of the new regimen, medical professionals closely monitor patients’ blood pressure levels and adjust treatment plans accordingly. The study found that nearly 50% of patients achieved a reduction in the number of antihypertensive medications used within 12 weeks after the surgery, marking a significant improvement in their quality of life and reducing the risk of long-term medication side effects.
This research not only brings new hope to patients with resistant hypertension but also provides fresh insights into the clinical management of hypertension. As research progresses, it is expected that more patients will benefit from this new approach.
【来源】http://www.chinanews.com/life/2024/03-15/10181142.shtml
Views: 1